Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum WELL Health Technologies Corp T.WELL

Alternate Symbol(s):  WHTCF | T.WELL.DB

WELL Health Technologies Corp. is a Canada-based practitioner-focused digital healthcare company. Its healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. Its business units include Canadian Patient Services, WELL Health USA Patient and Provider Services, and SaaS and Technology Services... see more

TSX:WELL - Post Discussion

WELL Health Technologies Corp > Scotiabank Raises Target
View:
Post by retiredcf on Dec 16, 2024 8:55am

Scotiabank Raises Target

Scotia’s Kevin Krishnaratne bumped his Well Health Technologies Corp.  target to $7 from $6 with a “sector outperform” rating. The average is $8.37.

“Last week, WELL announced that it had closed an $50-million preferred share private placement to help fund its SaaS business, now branded as WELLSTAR, ahead of its spinout planned to occur by the end of 2025,” he said. “The financing values WELLSTAR at 4.0 times PF 2025 Sales, higher than the 2.5 times our prior sum-of-the-parts valuation was reflecting. We’ve updated our model to include two acquisitions WELLSTAR made concurrent with the financing ($15-million of LTM [last 12-month] revenue at 20-per-cent Adj. EBITDA margins), in addition to increasing our target multiple used for WELLSTAR to 4.0x sales. Our target for WELL moves to $7 (prior $6), but we see potential for further upside from many of the company’s other businesses, including Canadian Clinics (M&A pipeline has been increasing) and at Wisp and Circle Medical (strategic reviews at both were recently noted as progressing well during Q3′s earnings call).”



Comment by PT12345 on Dec 16, 2024 9:12am
GLTA  WELL longs  btw although I appreciate these "analysts" new targets  somwhat amused by this "7$"  target  outstanding ;-)  probe must have been done by Scotia - for them to feel that a target of 20cents from here is what they hope for in the next 12 months......     comical really   20cents thats it!!!!
Comment by PT12345 on Dec 16, 2024 12:16pm
WELL Health Technologies Corp. (WELL.TO) 7.00+0.21(+3.10%) SCOTIA "analyst"  right on with his target prediction     :-O    too funny these guys
Comment by kentucky77 on Dec 16, 2024 4:34pm
The wisards at Scotia seem to be late to the party... with cheap wine.
Comment by kentucky77 on Dec 16, 2024 4:35pm
The wisards at Scotia seem to be late to the party... with cheap wine.  $7.00 ???
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities